Safety and Tolerability of Oral CM082 in Patients With wAMD
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This is a Phase II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and
Preliminary Efficacy of Intermittent Oral Dosing of CM082 tablets in Chinese Patients With
wAMD.